Heart Failure, Preserved Ejection Fraction: Clinical Trials

2 trials for Heart Failure, Preserved Ejection Fraction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 not yet recruiting. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Not yet recruiting 2
Phase 11Not yet recruiting 1

Follow Heart Failure, Preserved Ejection Fraction: new trials by email Literature Review of Heart Failure, Preserved Ejection Fraction trials Research Report on Heart Failure, Preserved Ejection Fraction

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Bimagrumab in Participants With HFpEF
Bimagrumab, Placebo - Heart Failure, Diastolic, Diastolic Heart Failure
Phase 2Not yet recruitingEli Lilly and Company5402026-11-012026-11-06
Randomized Double-blind Controlled Clinical Study of SGLT-2i Combined With Probiotic Preparations in Elderly Patients With HFpEF
Henggliflozin Combined with Probiotics, Henggliflozin, double placebo - Heart Failure, Preserved Ejection Fraction
Phase 1 / Phase 2Not yet recruitingThe First Affiliated Hospital of Air Force Medicial University1622026-07-012026-07-07

Narrower conditions

Heart Failure, Diastolic (2)  ·  Sarcopenia (1)

Broader conditions

Cardiovascular Diseases (2)  ·  Heart Diseases (2)  ·  Heart Failure (2)  ·  Atrophy (1)  ·  Muscular Atrophy (1)  ·  Nervous System Diseases (1)  ·  Neurologic Manifestations (1)  ·  Neuromuscular Manifestations (1)  ·  Pathological Conditions, Anatomical (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Interventions

Probiotics (1)  ·  bimagrumab (1)

Sponsors

Eli Lilly and Company (1)  ·  The First Affiliated Hospital of Air Force Medicial University (1)

Countries

China (1)  ·  Hungary (1)  ·  Italy (1)  ·  Poland (1)  ·  United States (1)